Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers

S. F. BUTLER ; C. BENOIT ; BUDMAN S. H. ; K. C. FERNANDEZ ; C. McCORMICK ; S. WING VENUTI ; N. KATZ | 2006
Dans Harm Reduction Journal (Vol.3, n°5, 2006) Article : Périodique

Background: The growing trends in opioid abuse, assessment of the abuse liability of prescription opioid products, and growing efforts by the pharmaceutical industry to develop 'abuse-resistant' formulations highlight a need to understand the fe[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Support of supervised injection facilities by emergency physicians in Canada

N. KATZ ; L. LEONARD ; L. WIESENFELD ; J. J. PERRY ; V. THIRUGANASAMBANDAMOORTHY ; L. CALDER | 2017
Dans International Journal of Drug Policy (Vol.49, November 2017) Article : Périodique

Background: Despite evidence supporting the implementation of supervised injection facilities (SIFs) by multiple stakeholders, no evaluation of emergency physicians' attitudes has ever been documented towards such facilities in Canada or interna[...]

Plus d'info

Ajouter à la sélection

Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions

N. KATZ ; R. C. DART ; E. BAILEY ; J. TRUDEAU ; E. OSGOOD ; F. PAILLARD | 2011
Dans American Journal of Drug and Alcohol Abuse (Vol.37, n°4, 2011) Article : Périodique

Background: Transdermal and solid oral prescription opioid (PO) formulations can be abused by ingesting (with or without tampering), snorting, or injection (both requiring tampering). Objective: To determine the patterns of tampering with POs fo[...]

Plus d'info

Ajouter à la sélection

Lien externe